Rupalben Devani

• Provided assistance in daily living activities by dressing, grooming, bathing, and toileting patients.
• Maintained clean, safe, and well-organized patient environment.
• Assisted patients with dressing, grooming and feeding needs, helping to overcome, and adapt to mobility restrictions.
• Kept accurate records of patients' care, condition, and progress.
• Assisted in feeding patients by offering fluids and snacks and recording amounts consumed in logbook
• Assisted with feeding and monitored intake to help patients achieve nutritional objectives.
• Answered call lights and supported patient comfort and safety by adjusting bed rails and equipment.
• Promoted good oral and personal hygiene by aiding patients with shaving, bathing, and teeth brushing.

• Provided total hygiene care 10-15 patients per shift by assisting with skincare, bathing, and toileting.
• Evaluated patients to identify and address wounds, behavioral concerns, and medically relevant symptoms.
• Promoted patient socialization, self-care and development by recognizing and using patient strengths to motivate patient.
• Documented vital signs to inform nurses and physicians of any changes in patient status.
• Promoted good oral and personal hygiene by aiding patients with shaving, bathing, and teeth brushing.
• Assisted with feeding and monitored intake to help patients achieve nutritional objectives.
• Kept accurate records of patients' care, condition, and progress.

A Randomized Open Label Two Treatment Two Period, Two Sequence, Single Dose, Crossover, Bioequivalence Study Of Leuprolide Acetate 7.5 mg Depot Suspension of Sun Pharma Limited India and Lupon Depot (Leuprolide Acetate) 7.5 mg Depot Suspension Of Tap Pharma Lake Forest 11 60045 USA under Fasting conditions in 60 prostatic Carcinoma Patients undergoing initial Therapy.

A Phase 3 Open Label Baseline Controlled Multicenter Sequential Dose of Titration Study to assess the long term efficacy and safety and the pharmacokinetics of Solifenacin Succinate Suspension in patients from 5 to less then 18 years of age with neurogenic Detrusor Overactivity (NDO)

A Multicenter randomized open label two treatment, two period, two sequence, multiple dose, cross over bioequivalence study of Everolimus 10 mg tablet once daily manufactured by Par Pharma 1 Ram Ridge Road, Spring Valley, NY 100977, USA with Afinitor (Everolimus) 10 mg tablet manufactured by Novartis Pharma Stein Switzerland and distributed by Novartis Pharma Corporation East Hanover MJ 07936 in Advance Renal Cell Carcinoma patients under fasting condition.

A Prospective Randomized Multiple dose multi-center Comparative Parallel clinical study of Evaluate the efficacy, safety, Immunogenicity and pharmacokinetics of an intravenous infusion of Bevacizumab (Test product, Hetero) and reference medicinal product patients of metastatic Colorectal Cancer.

A Prospective Randomized Open Label Three Arm Parallel Multicenter Study to evaluate efficacy and safety of Metformin with/without concomitant administration of Thymoquinone in patients with Type 2 Diabetes Mellitus.